Roberto De Ponti

Roberto De Ponti currently serves as a Board Observer at Geneos Therapeutics, Epsilogen Ltd, and iOnctura, while holding the position of Managing Director and General Partner at 3B Future Health Fund I & II since January 2022. Additionally, Roberto has been active as an Advisor at Claris Ventures SGR SpA and a Board Member at OncoResponse Inc., contributing valuable expertise to the board of Fore Biotherapeutics until September 2023 and GreenBone Ortho S.p.A. until October 2022. Previous roles include influential leadership positions at Helsinn Group from June 2008 to December 2021, overseeing Corporate New Ventures, Strategic Investments, and Business Development, along with serving as a Board Observer at Aadi Bioscience, Inc. from March 2017 to April 2021.